Literature DB >> 34791446

Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines.

Julian Stumpf1,2, Anna Klimova3, René Mauer4, Anne Steglich1, Florian Gembardt1, Heike Martin5, Grit Glombig6, Kerstin Frank7, Torsten Tonn8,9, Christian Hugo1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34791446      PMCID： PMC8767822          DOI： 10.1093/ndt/gfab324

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  1 in total

1.  Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study.

Authors:  Julian Stumpf; Jörg Schwöbel; Tom Lindner; Leona Anders; Torsten Siepmann; Claudia Karger; Jan Hüther; Heike Martin; Petra Müller; Robert Faulhaber-Walter; Torsten Langer; Holger Schirutschke; Thomas Stehr; Frank Meistring; Annegret Pietzonka; Kirsten Anding-Rost; Katja Escher; Frank Pistrosch; Jens Schewe; Harald Seidel; Kerstin Barnett; Thilo Pluntke; Simon Cerny; Alexander Paliege; Ingolf Bast; Anne Steglich; Florian Gembardt; Friederike Kessel; Hannah Kröger; Patrick Arndt; Jan Sradnick; Kerstin Frank; Anna Klimova; René Mauer; Xina Grählert; Torsten Tonn; Christian Hugo
Journal:  Lancet Reg Health Eur       Date:  2022-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.